Status:
COMPLETED
Lymphoma Follow-up
Lead Sponsor:
National Institute on Aging (NIA)
Conditions:
Lymphoma
Eligibility:
All Genders
21+ years
Brief Summary
This follow-up protocol is designed to evaluate participants who have previously been lymphoma patients treated on approved clinical studies of the National Institutes of Health.
Detailed Description
The intent of this protocol is to accrue up to 800 volunteers who are interested in participating in NIA research studies as part of follow-up for previous cancer treatment at NIH. Participants will b...
Eligibility Criteria
Inclusion
- Previously treated on an approved NCI/NIH protocols
- Willing and able to provide informed consent for current NIA protocol
- Rare, unusual, interesting or unknown condition that requires diagnosis
Exclusion
- Does not meet the criteria of any previously-approved NIH Protocol.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00744120
Start Date
October 1 2003
End Date
September 1 2013
Last Update
December 20 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIA Clinical Research Unit
Baltimore, Maryland, United States, 21225